Dr. Molly O'Neill is the CEO of Vanguard, a company that invests in health care and other industries. She says she has been working on continuous glucose monitoring (CGM) since 2014. "I think we should all be measuring our blood sugar before we get diabetes," said O'Neill. 'There's really good reasons why you would not take psychedelics,' he added.